1. Treatment with osimertinib significantly improved progression-free survival, compared to placebo, in patients with unresectable stage III EGFR-mutated NSCLC 2....

1. Although capecitabine or XELOX did not improve overall survival when compared to PF, efficacy was comparable suggesting single-agent capecitabine...

1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy did not appear to improve progression-free survival...

1. When compared to upfront surgery, neoadjuvant chemotherapy using mFOLFOX or CAPOX did not appear to significantly improve 3-year disease-free...

1. Invasive disease-free survival was significantly higher in patients receiving adjuvant ribociclib + NSAI when compared to patients receiving NSAI...

Acetaminophen for Fever in Critically Ill Patients with Suspected Infection Acetaminophen is a commonly used anti-pyretic in patients admitted to...

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia BRAF V600E has been identified as the genetic lesion responsible for...

Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects,...

Community Acquired Pneumonia Requiring Hospitalization among US Adults Community acquired pneumonia is one of the leading infectious causes of hospitalization...

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes HMG-CoA reductase inhibitors (statins) lower LDL cholesterol levels and reduce the...